Precision For Medicine

Seeking Medical Directors/Senior Medical Directors ready for the challenge of cell and gene therapy. Poland - https://lnkd.in/g-DZDfZ5 Hungary - https://lnkd.in/g7SNDg2P Romania - https://lnkd.in/gKxSBKSW Serbia - https://lnkd.in/gfk-B_q4 Slovakia - https://lnkd.in/gHmDqJP3

Precision is excited to be attending the Asia Bio Innovation Summit (ADC & CGT) on August 14–15, where global leaders in biotech and precision medicine will gather to shape the future of healthcare. Jing Ping Yeo and 阴振飞 Zhenfei Yin will be representing Precision for Medicine at the event. Jing Ping will also be delivering a special address titled “The Evolving Role of APAC in Drug Development for Oncology and Rare Indications” during the dinner event on August 14. Don’t miss it! Looking forward to connecting with innovators and partners across Asia. #AsiaBioInnovationSummit #PrecisionForMedicine #Biotech #Singapore #LifeSciences #PrecisionMedicine

Striking gold in drug development doesn’t happen by chance. It starts with the right map, the right tools, and the right biospecimens. At Precision for Medicine, we treat the process of prospective biospecimen collection like a strategic mining operation. From feasibility planning and global site activation to sample processing and regulatory-ready data delivery, we manage every step with scientific rigor and operational precision—so you can stay focused on discovery. In our latest article, you’ll uncover: -Why prospective biospecimen collections are essential for high-impact biomarker research and drug development -Five critical steps to ensure collection success -How Precision for Medicine delivers value beyond the sample -What to look for in a biospecimen collection partner Don’t pan for gold—mine it strategically. Read the full article to learn how prospective biospecimen collections can accelerate your path to breakthrough discoveries. https://lnkd.in/eaJ2k-g7

When a trial starts slipping, the clock doesn’t slow down. Sponsors come to Precision when… …Enrollment milestones are missed …Dropout rates are rising …Site engagement is falling apart …Data collection is inconsistent …Accountability from the CRO is lacking Rescue/transition studies require more than a handoff, especially in oncology and rare diseases. Our experienced teams build trust, restore momentum, and deliver with precision. If you're facing challenges mid-trial, talk with us before the delay becomes a derailment. Case Study: Effective Management of a Rescue Study https://lnkd.in/eKnS6cTy?

What’s next for smoldering multiple myeloma? At the recent FDA ODAC meeting, external experts voted 6–2 in favor of the benefit-risk profile for daratumumab (Darzalex Faspro) in patients with smoldering multiple myeloma, a precursor condition that can progress to active disease. If approved, this would mark the first FDA-approved treatment for this patient population and set a precedent for earlier intervention in myeloma. In this special edition of CMO Confidential, our Chief Medical Officer, Harpreet Singh, MD, provides a detailed recap, offering insight into the regulatory implications, clinical considerations, and what this means for future trials in high-risk populations. Watch the full video to hear her take on this potential shift in the treatment landscape. #MultipleMyeloma #RegulatoryAffairs #CMOConfidential

Join experts from Precision for Medicine, Avidity Biosciences, Inc., and Indaptus Therapeutics, Inc. to explore how PCR-based molecular monitoring is breaking barriers in clinical trials. Focusing on smarter assay design and more efficient data generation, this webinar will explore innovative strategies advancing research in gene therapy, cell therapy, and oncology. Transform your trial strategy today: https://lnkd.in/ebjRgz-j #ddprc

Elevate your career and your impact on rare disease research. Senior Regulatory & Start Up Specialist (Serbia) - https://lnkd.in/gFg7hy8d Regulatory and Start Up Specialist (Belgium) - https://lnkd.in/g_gNK-wn

Our executives get around! Precision for Medicine's expanded lab facilities in Frederick, Maryland now have over 118,000 square feet for advanced research, kitting, sample storage and hosting special guests.

Happy National Intern Day! As the summer winds down, we’re celebrating the incredible journey our Precision interns embarked on over the last few months. They’ve brought curiosity, creativity, and commitment to every challenge, leaving a lasting mark on our teams and projects. From fresh perspectives to meaningful contributions, their impact has been inspiring. Thank you for spending your summer with us. And, for shaping the future with your passion and purpose. #NationalInternDay #ThankYouInterns

Is your immune profiling strategy built for today’s immuno-oncology trials? Do you lead with a hypothesis, or let high-dimensional data guide discovery? Can your assays align across tissue and blood using matched samples? Will your data strategy scale as your trial progresses? In our on-demand webinar, Precision’s experts share how to design immune profiling strategies that balance scientific depth with operational efficiency—leveraging MIF, flow cytometry, and AI-powered analytics to accelerate discovery without sacrificing quality. Watch now and rethink your approach: https://lnkd.in/eH9fSDvi